0001836562-22-000001.txt : 20220202 0001836562-22-000001.hdr.sgml : 20220202 20220202122720 ACCESSION NUMBER: 0001836562-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220202 DATE AS OF CHANGE: 20220202 EFFECTIVENESS DATE: 20220202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hopewell Therapeutics, Inc. CENTRAL INDEX KEY: 0001836562 IRS NUMBER: 823045662 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-431881 FILM NUMBER: 22582370 BUSINESS ADDRESS: STREET 1: 405 WALTHAM STREET CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617 921 7082 MAIL ADDRESS: STREET 1: 405 WALTHAM STREET CITY: LEXINGTON STATE: MA ZIP: 02421 D 1 primary_doc.xml X0708 D LIVE 0001836562 Hopewell Therapeutics, Inc. 310 WEST CUMMINGS PARK WOBURN MA MASSACHUSETTS 01801 617 921 7082 DELAWARE None None Corporation true 2018 QIAOBING XU 310 WEST CUMMINGS PARK WOBURN MA MASSACHUSETTS 01801 Executive Officer Director THOMAS V HENNESSEY 310 WEST CUMMINGS PARK WOBURN MA MASSACHUSETTS 01801 Director XUTIAN JING 310 WEST CUMMINGS PARK WOBURN MA MASSACHUSETTS 01801 Director HOWARD ROSEN 310 WEST CUMMINGS PARK WOBURN MA MASSACHUSETTS 01801 Director JAKE XIA 310 WEST CUMMINGS PARK WOBURN MA MASSACHUSETTS 01801 Director Biotechnology $5,000,001 - $25,000,000 06b false 2022-01-18 false true false 0 7108361 7108361 0 false 4 0 0 0 false Hopewell Therapeutics, Inc. /s/ QIAOBING XU QIAOBING XU CEO 2022-02-02